Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -85,403 | -72,710 | -50,801 | -31,752 | -276,126 |
| Depreciation Amortization | 4,811 | 3,921 | 2,748 | 1,428 | 5,621 |
| Accounts receivable | 32,626 | 32,773 | 31,686 | -1,726 | 6,113 |
| Accounts payable and accrued liabilities | 687 | -1,537 | 1,573 | -826 | -3,130 |
| Other Working Capital | -30,959 | -8,554 | -15,116 | -11,733 | 15,341 |
| Other Operating Activity | 9,521 | 1,861 | -10,347 | 14,997 | 59,204 |
| Operating Cash Flow | $-68,717 | $-44,246 | $-40,257 | $-29,612 | $-192,977 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,870 | 5,404 | 22,069 | 14,844 | 125,064 |
| PPE Investments | -246 | -156 | -156 | -127 | -1,198 |
| Investing Cash Flow | $8,624 | $5,248 | $21,913 | $14,717 | $123,866 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -892 | -657 | -460 | -227 | -947 |
| Common Stock Issued | 60,181 | 60,274 | 9,461 | 9,374 | 3,064 |
| Other Financing Activity | -7 | -7 | 14,816 | 14,994 | -107 |
| Financing Cash Flow | $59,282 | $59,610 | $23,817 | $24,141 | $2,010 |
| Beginning Cash Position | 25,987 | 25,987 | 25,987 | 25,987 | 93,088 |
| End Cash Position | 25,176 | 46,599 | 31,460 | 35,233 | 25,987 |
| Net Cash Flow | $-811 | $20,612 | $5,473 | $9,246 | $-67,101 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,717 | -44,246 | -40,257 | -29,612 | -192,977 |
| Capital Expenditure | -246 | -156 | -156 | -127 | -1,223 |
| Free Cash Flow | -68,963 | -44,402 | -40,413 | -29,739 | -194,200 |